跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Salbuvan
Approved
STANDARD
Salbuvan
Philmed Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c2da8dcb476340e7
Company
Philmed Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
c2da8dcb476340e7
Drug Approval Philippines Name
Salbuvan
Product Name
Salbuvan
Registration Number
DR-XY20961-B
Brand Name
Salbuvan
Generic Name
Salbutamol (As Sulfate)
Dosage Form
Tablet
Dosage Strength
2 mg
Manufacturer
Philmed Laboratories, Inc.
Trader
Ivancor Importer
Issuance Date
28 September 2022
Expiry Date
02 September 2027
Pharmacologic Category
Selective Beta -2-Adrenoreceptor Agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c2da8dcb476340e7
Type
Standard
Back to Philippines FDA Approvals
Salbuvan - Philippines FDA Drug Approval Details